Kolotkin RL, Williams V, Ervin CM, Williams N, Meincke HH, Qin S, von Huth Smith L, Fehnel SE. Validation of a new measure of quality of life in obesity trials: IWQOL-Lite Clinical Trials Version. Poster presented at the 2018 Obesity Week Conference; November 13, 2018. Nashville, TN. doi: 10.1111/cob.12310
Fehnel S, Ervin C, McLeod L, Carson RT, Reasner D, Hanlon J, Eremenco S, Coons SJ, PRO Consortium’s Irritable Bowel Syndrome Working Group. Psychometric evaluation of the diary for irritable bowel syndrome symptoms-constipation (DIBSS-C). Poster presented at the 2018 ISPOR 21st Annual European Congress; November 13, 2018. Barcelona, Spain.
McLeod LD, Fehnel SE, Cappelleri JC. Patient-reported outcome measures: development and psychometric evaluation. In: Peace KE, Chen DG, Menon S, editors. Biopharmaceutical applied statistics symposium. Volume 1 Design of clinical trials. 1 ed. Singapore. Springer Nature Singapore Pte Ltd; 2018. p.317-46. doi: 10.1007/978-981-10-7829-3
DiBenedetti DB, Brown TM, DeMuro CJ, Ervin C, Lewis SA, Fehnel SE. Conducting patient interviews within a clinical trial setting. RTI Press. 2018 Aug. doi: 10.3768/rtipress.2018.op.0054.1808
Hanlon J, Ervin C, McLeod L, Butler A, Carson R, Coons S, Fehnel S, Kovacs S. Case study: the Diary of Irritable Bowel Syndrome Symptoms (DIBSS). Presented at the Ninth Annual PRO Consortium Workshop; April 25, 2018. Silver Spring, MD.
Hill CD, Fehnel SE, Bobula JD, Yu H, McLeod LD. Development and preliminary validation of the Menopause Symptoms Treatment Satisfaction Questionnaire (MS-TSQ). Menopause. 2007 Nov 1;14(6):1047-55.
Williams RE, Kalilani L, DiBenedetti D, Zhou X, Fehnel SE, Clark RV. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas. 2007 Nov 1;58(2007):348-58.
McLeod LD, Fehnel SE, Zografos LJ, Sander S, Curtice T, Shah H. The impact of restless legs syndrome on diagnosed and undiagnosed sufferers: results of a web-based patient survey. Poster presented at the SLEEP 2007 21st Annual Meeting of the Associated Professional Sleep Societies; June 2007.
Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007 May 1;5(5):534-40.
Mangel AW, Fehnel SE. Adequate relief: the gold standard primary endpoint in IBS. Presented at the 2007 Digestive Disease Week; May 1, 2007.
McLeod LD, Fehnel SE, Zografos LJ, Sander SD, Curtis TG, Shah H. The impact of restless legs syndrome on various dimensions of life: results of a web-based patient survey. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. [abstract] Value Health. 2007 May; 10(3):A95.
Mahajan S, Fehnel SE, Thompson M, Minnich M, Northcutt A, Bell T. Comparing the effects of irritable bowel syndrome on work productivity and healthcare utilization with those of asthma and migraine: results from a web-based patient survey. Presented at the 2007 Digestive Disease Week; May 1, 2007.
Williams VS, Edin HM, Hogue SL, Fehnel SE, Baldwin DS. Antidepressant-induced sexual dysfunction in three European countries: prevalence and impact in a cross-sectional survey replication. J Psychopharmacol. 2007;21(Suppl):A39.